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1. Cancer 
Cancer is a disease characterized by uncontrolled multiplication and spread of abnormal 
forms of the body's own cells. It is one of the major causes of death in the developed nations. 
One in three people will be diagnosed with cancer during their lifetime, and in 2001 (for 
example) 270000 new cases were reported in the United Kingdom. Cancer is also responsible for 
approximately one-quarter of all deaths in the United Kingdom, with lung and bowel cancer 
comprising the largest category, closely followed by breast and prostate cancer. At first sight, 
incidence figures for the past 100 years or so give the impression that the disease is increasing in 
developed countries, but cancer is largely a disease of later life, and with advances in public 
health and medical science many more people now live to an age where they are more liable to 
contract cancer.1 
The ancient origin of the term cancer derives from the Latin word “crab”, cancer- 
presumably because a cancer adheres to any part that it seizes upon in obstinate manner like a 
crab. Two characteristics features define a cancer cell growth not regulated by external signals 
(i.e. autonomous) and the capacity to invade tissue and metastasize and colonized distant sites. 
The first of these features, the uncontrolled growth of abnormal cell is a property of 
neoplasms or new growth. A neoplasm may be begin or malignant. If invasion, the 2nd cardinal 
feature of cancer is present, the neoplasm is malignant. Cancer is a synonym for malignant 
neoplasm. Cells that have undergone neoplastic transformation usually express cell surface 
antigens that may be of normal fetal type, may display other signs of apparent immaturity and 
                                                                                                                                                    Introduction 
 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52                                                        2 
 
may exhibit qualitative or quantitative chromosomal abnormalities, including various 
translocations and the appearance of amplified gene sequences.  
Cancer refers to the hyper proliferation of cells that have lost the ability to be controlled 
by normal cell signals. Cancer cells have the ability to proliferate independent of their 
environment and are capable of metastasizing, or colonizing other tissues in the body. 
There are three basic characteristics of early cancer cells. The first is that they have lost 
the ability to undergo apoptosis, or programmed cell death. Cells that have suffered irreparable 
DNA damage activate specific proteases and nucleases that destroy the proteins and DNA of the 
cell, thereby effectively limiting the spread of potentially deleterious mutations. Cancer cells 
have often obtained mutations in genes involved in regulating this pathway.  
Secondly, cancer cells have lost the ability to stop dividing. Normal cells require 
extracellular signals, such as growth factors, in order to activate pro-growth pathways. This need 
for extracellular stimulation is one means of regulating cell growth that cancer cells manage to 
bypass. This means that cancer cells proceed through the cell cycle and continue to divide 
indefinitely. 
Thirdly, cancer cells often have abnormal telomerase activity. Telomeres are the 
specialized regions on the ends of chromosomes that form t-loops - these protect the ends and 
distinguish double-stranded DNA breaks from normal ends. Telomerase is an enzyme that acts to 
lengthen the telomeres on aging chromosomes in certain cell types. A portion of the telomere is 
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lost during each DNA replication. When telomeres are shortened to the point that they cannot 
form t-loops, cells undergo senescence, where the cell remains in an undividing state, or 
apoptosis. Cancer cells, which are continually dividing, often express telomerase or have 
increased telomerase activity in order to circumvent the telomere problem. These three basic 
characteristics are the premise for malignancy and enable the accumulation of more genetic and 
chromosomal abnormalities, which further lead to increased malignant and metastatic 
phenotypes.  
There are several different kinds of cancer but they all essentially fall into three basic 
categories: carcinomas, sarcomas and leukemia/lymphomas. Both carcinomas and sarcomas are 
solid tumors, or tumors consisting of a dense collection of cancer cells that has its own blood 
supply. 
 Carcinomas are solid malignant lesions originating in the epithelial tissue. These are 
often found in glands or the lining of various organs. Examples of carcinomas would be breast 
cancer and prostate cancer, and occur most frequently in older patients. Sarcomas are solid 
tumours of the connective tissue, such as bone and muscle. There is a higher incidence of 
sarcoma in younger patients than in older ones. Finally, leukemia and lymphoma are 
malignancies originating in immune or haematopoeitic cells and can be found in patients 
representing a wide age range. These cancers are commonly referred to as disseminated cancers 
as they do not form masses of cells, but instead are found throughout the vascular system. 
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1.1 The Special Characteristics of Cancer Cells  
Cancer cells manifest, to varying degrees, four characteristics that distinguish them from 
normal cells. These are: 
• Uncontrolled proliferation.  
• Differentiation and loss of function. 
• Invasiveness. 
• Metastasis. 
1.2 Causes of Cancer  
The incidence, geographic distribution, and behavior of specific types of cancer are 
related to multiple factors, including sex, age, race, genetic predisposition, and exposure to 
environmental carcinogens. Out of these factors, environmental exposure is probably most 
important. Exposure to ionizing radiation has been well established to be a significant risk factor 
for a number of cancers, including acute leukemia, thyroid cancer, breast cancer, lung cancer, 
soft tissue sarcoma, and basal cell skin cancers. Chemical carcinogens (particularly those in 
tobacco smoke) as well as azo dyes, aflatoxins, asbestos, benzene, and radon have been clearly 
implicated in cancer induction in humans and animals. Viruses have been implicated as the 
etiologic agents of several human cancers. Expression of virus-induced neoplasia probably also 
depends on additional host and environmental factors that modulate the transformation process. 
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1.3 Types of Cancer 
Pathological classification: 
• Carcinoma   : Malignant tumors that arises from epithelial cell. 
• Melanoma   : Cancerous growth of melanocytes, skin epithelial   
                  cell that produce the pigment melanin. 
• Sarcoma   : Cancer arising from muscle cell or connective tissue. 
• Osteogenic Sarcoma       : The most frequent type of childhood cancer  
          Destroys normal bone tissue. 
• Leukemia   : It is a cancer of blood forming organs characterized  
           By rapid growth of abnormal leucocytes. 
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1.4 Melanoma Cancer 
Melanoma is a form of skin cancer that arises from melanocytes - the cells that produce 
pigment. Melanoma may begin in association with a mole. Melanocytes produce a pigment 
called melanin that gives the skin its color and protects it from sun damage. Darker skin has 
more melanin and more protection. Melanocytes often cluster together and form moles (nevi). 
Most moles are benign, but some may go on to become malignant melanomas. 
1.5 Types of Melanoma 5 
Melanoma, acral-lentiginous:  
One of the four clinical types of malignant melanoma is the most common type in non 
whites but uncommon in whites. It starts as an irregular enlarging black flat spot (macule), most 
often on the palm and sole, less often on a mucosal surface, such as the vulva or vagina 
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.Melanoma, lentigo maligna:  
One of the four clinical types of malignant melanoma and the slowest growing one. It 
typically begins as a patch of mottled pigmentation that is dark brown, tan, or black on sun-
exposed skin, such as on the face. 
Melanoma, nodular   
One of the four clinical types of malignant melanoma, typically presents as a raised, 
distinct, bluish-black tumor that may be encircled by particularly pale skin, most often in middle-
aged or older adults. 
Melanoma, superficial spreading:  
One of the four clinical types of malignant melanoma, the most common type in whites, 
typically presents as a raised, irregular, colored area that starts in a mole-like shape but spreads 
across the skin. 
Stages of Melanoma Progression: 
In situ melanoma: 
The earliest form of melanoma, it is small and does not extend beneath the surface of the skin. 
Stage I melanoma: 
Tumors are less than 2mm in thickness, found in the outer layer of the skin (epidermis) 
and/or the upper part of the inner layer of the skin (dermis). 
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Stage II melanoma 
The carcinoma spreads to the lower part of the inner layer of the skin (dermis) but not 
into the tissue below. It can spread into fat tissue as well. 
Stage III melanoma 
The carcinoma spreads to near by lymph nodes. 
Stage IV melanoma 
The carcinoma spreads beyond the skin to distant sites or organs. Melanoma can also 
start in the mucous membranes of the mouth, anus and vagina, in the eye or other places in the 
body where melanocytes are found. 
1.6 Sarcoma 
A sarcoma (from the Greek 'sarx' meaning "flesh") is a cancer of the connective tissue 
(bone, cartilage, fat) resulting in mesoderm proliferation. 
This is in contrast to carcinomas, which are of epithelial origin (breast, colon, pancreas, 
and others). However, due to an evolving understanding of tissue origin, the term "sarcoma" is 
sometimes applied to tumors now known to arise from epithelial tissue. The term soft tissue 
sarcoma is used to describe tumors of soft tissue, which includes elements that are in connective 
tissue, but not derived from it (such as muscles and blood vessels). 
Classification 
Tissue: Sarcomas are given a number of different names, based on the type of tissue from 
which they arise. For example, osteosarcoma arises from bone, chondrosarcoma arises from 
cartilage, and leiomyosarcoma arises from smooth muscle. Sarcomas strike people in all age 
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ranges, but they are very rare, accounting for only 1% of all cases of cancer. Soft tissue 
sarcomas, such as leiomyosarcoma, chondrosarcoma, and gastrointestinal stromal tumor (GIST), 
are more common in adults than in children. GIST is the most common form of sarcoma, with 
approximately 3000-3500 cases per year in the United States.This should be compared with 
breast cancer, with approximately 200,000 cases per year in North America. Bone sarcomas, 
such as osteosarcoma and Ewing's sarcoma, are more common in children than in adults. These 
tumors most commonly strike adolescents and young adults between the ages of 12 and 25. 
Grade: In addition to being named based on the tissue of origin, sarcomas are also assigned a 
grade, such as low grade or high grade. Low grade sarcomas are usually treated surgically, 
although sometimes radiation therapy or chemotherapy is used. High grade sarcomas are more 
frequently treated with chemotherapy. Since these tumors are more likely to undergo metastasis 
(spreading to distant sites), these tumors are treated more aggressively. Childhood sarcomas are 
almost always treated with a combination of surgery and chemotherapy, and radiation is 
frequently used as well. The recognition that childhood sarcomas are sensitive to chemotherapy 
has dramatically improved the survival of patients. For example, in the era before chemotherapy, 
long term survival for patients with localized osteosarcoma was only approximately 20%, but 
now has risen to 60-70%. 
Fibrosarcoma 
Fibrosarcoma (fibroblastic sarcoma) is a malignant tumor derived from fibrous 
connective tissue and characterized by immature proliferating fibroblasts or undifferentiated 
anaplastic spindle cells. 
Pathology 
The tumor may present different degrees of differentiation: low grade (differentiated), 
intermediate malignancy and high malignancy (anaplastic). Depending on this differentiation, 
tumor cells may resemble mature fibroblasts (spindle-shaped), secreting collagen, with rare 
mitoses. These cells are arranged in short fascicles which split and merge, giving the appearance 
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of "fish bone". Poorly differentiated tumors consist in more atypical cells, pleomorphic, giant 
cells, multinucleated, numerous atypical mitoses and reduced collagen production. Presence of 
immature blood vessels (sarcomatous vessels lacking endothelial cells) favors the bloodstream 
metastasizing 
1.7 How Does Cancer Arise 
Cancer arises most commonly in older patients but can occur at any age. Different 
cancers are more prevalent in certain age groups and are rarely found in people outside that age 
range. An example would be prostate cancer, where it is very uncommon for a man under the age 
of 40 to be diagnosed with the disease. It makes sense that cancer occurs predominantly in the 
elderly population, as cancer is the result of accumulated genetic mutations. As individual ages 
they are more likely to have been exposed to chemicals, radiation and other events that cause 
DNA damage. As a result, these individuals are more likely to have mutations in genes allowing 
for cancerous behaviors. 
As mentioned above, characteristics like the ability to evade apoptosis; unregulated cell 
division and increased telomerase activity are all the results of genetic mutations that can lead to 
cancer. These mutations commonly occur in what are called proto-oncogenes and tumour 
suppressor genes. Proto-oncogenes are genes coding for proteins involved in cell cycle 
progression and growth signalling; when mutated these genes are called oncogenes (see Figure 
2). Oncogenes are autosomal dominant, meaning that only one mutated allele is necessary for 
cancerous behavior to develop. Several oncogenes have been identified in many types of cancers, 
including myc, the bcl family of genes and ras.     
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Figure 2. Oncogenes are mutated forms of normal cellular genes involved in growth signalling 
pathways (proto-oncogenes). When these genes become mutated the cell does not require the 
presence of pro-growth signals (e.g. growth factors) in order to undergo cell division. 
In contrast, tumour suppressor genes are often involved in regulating apoptosis (see 
Figure 3). Cells that have sustained damage to their DNA apoptose under the control of tumour 
suppressors; when both alleles are mutated to be non-functional cells fail to enter the apoptotic 
pathway. These cells continue to divide and are not subjected to further DNA repair attempts, 
resulting in increasing genomic instability and further mutations. These mutations often occur in 
other oncogenes and tumour suppressor genes, conferring more cancerous behaviors. If either of 
these kinds of mutations exists or occurs in someone then they are at a higher risk of developing 
cancer. 
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Figure 3. Tumour suppressor genes are genes often involved in the apoptotic pathway. Normally 
tumour suppressors detect breaks or defects in the DNA - if present in low concentrations these 
proteins will pause the cell cycle and active DNA repair mechanisms. If present in high 
concentrations, tumour suppressors shut down the cell cycle or cause apoptosis. When these 
genes are mutated to be dysfunctional then the cell does not undergo either of these events. 
It is important to note that cancer results from the clonal expansion of one progenitor cell, 
or “mother” cell (the one that first obtained a mutation allowing for a “cancerous” phenotype). 
This means that all cells in a tumour should in fact be genetically identical to the parent cell and 
exhibit the same mutations, however, because mutations occur at a much higher rate in tumour 
cells, daughter cells may be more tumourogenic than the parent [4]. All that is required for 
cancer to develop is one cell among millions that is capable of developing independent of 
regulatory signals. 
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1.8 Importance of Cell Cycle Kinetics  
 
 
Tumor-suppressor genes act primarily through their influence on the cell cycle. The life 
cycle of a cell that divides can be described by a four-phase cell cycle composed of M phase, 
G1 phase, S phase, and G2 phase. M phase is the phase of mitosis, when the cell physically 
divides. G1 phase is the first Gap phase (or Growth phase), which occurs immediately after 
mitosis. During G1 the cell is synthesizing proteins and growing to achieve the size, a normal cell 
has before splitting into two, during mitosis. S phase is a phase of DNA Synthesis (DNA 
replication) in preparation for cell division. The G2 phase is characterized by DNA repair of 
errors introduced during DNA replication, and by preparation for the coming mitosis. Cells that 
cease dividing - or that rest for extended periods between divisions (such as liver cells) have 
temporarily or permanently exited the cell cycle by going into the G0 phase at the end of the 
G1 phase. 
 
                                                                                                                                                    Introduction 
 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52                                                        14 
 
1.9 Terminology of Cell Death6 
Cell death can occur by either of two distinct mechanisms, necrosis or apoptosis. In addition, 
certain chemical compounds and cells are said to be cytotoxic to the cell, that is, to cause its 
death. 
The two mechanisms of cell death may briefly be defined as  
• Necrosis 
• Apoptosis  
Necrosis 
“Accidental” cell death is the pathological process which occurs when cells are exposed to a 
serious physical or chemical insult. Necrosis begins with impairment of the cell’s ability to 
maintain homeostasis, leading to an influx of water and extracellular ions. Intracellular organelle, 
most notably the mitochondria, and the entire cell swell and rupture (cell lyses). Due to the 
ultimate break down of the plasma membrane, the cytoplasmic contents including lysosomal 
enzymes are released into extracellular fluid. Therefore in vivo, necrotic cell death is often 
associated with extensive tissue damage resulting in an inflammatory response.6 
Apoptosis 
“Normal” or “programmed” cell death is the physiological process by which unwanted or useless 
cells are eliminated during development and other normal biological processes. 
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Apoptosis or programmed cell death is a highly regulated pathway that is important in normal 
developmental processes as well as many diseases.7 Apoptosis can be initiated by a variety of 
different stimuli that lead to a convergence of biochemical signaling pathways into a common 
collection of executioner molecules. Apoptosis is a mode of cell death that occurs under normal 
physiological conditions and the cell is an active participant in its own demise (“cellular 
suicide”). 
 
It is most often found during normal cell turnover and tissue homeostasis, embryogenesis, 
induction and maintenance of immune tolerance, development of the nervous system and 
endocrine-dependent tissue atrophy. Cells undergoing apoptosis show characteristic 
morphological and biochemical features. These features include chromatin aggregation, nuclear 
and cytoplasmic condensation, partition of cytoplasm and nucleus into membrane bound-vesicles 
(apoptotic bodies) which contain ribosomes, morphologically intact mitochondria and nuclear 
material. In vivo, these apoptotic bodies are rapidly recognized and phagocytized by either 
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macrophages or adjacent epithelial cells. Due to this efficient mechanism for the removal of 
apoptotic cells in vivo no inflammatory response is elicited. 
1.10 Cancer Treatment  
 There are six main types of treatment for cancer and these are described below. It is fairly 
common for a combination of treatments to be used. 
Active surveillance (or watchful waiting) 
Some types of cancer grow very slowly and may cause no problems for many years. In 
this situation you may not need to have any treatment for some time, but your doctor will 
monitor you closely so that if the cancer does start to grow you can be given treatment at that 
time. 
Surgery 
An operation is done to remove the tumor. Surgery is often used if the cancer is only in 
one area of the body and has not spread. It may be used to remove lymph nodes if these are also 
affected by the cancer. It can sometimes be used to remove a cancer that has spread to another 
area of the body, but this is less common. The type of operation will depend on the area of the 
body affected by the cancer, and on the size and position of the tumor. 
Radiotherapy  
This is the use of high energy x-rays to destroy cancer cells, but cause as little harm as possible 
to normal cells. The radiotherapy is aimed at the affected area of the body and is very carefully 
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planned. It can cause side effects and the most common is tiredness. The side effects will depend 
on the part of the body that is being treated. 
Chemotherapy 
 Chemotherapy is the use of anti-cancer (cytotoxic) drugs to destroy cancer cells. There 
are more than 50 different chemotherapy drugs. Some are given as tablets or capsules but most 
are given by drip (infusion) into a vein. The drugs go into the bloodstream and travel throughout 
the body to treat the cancer cells wherever they are. Sometimes just one chemotherapy drug is 
used, but often a combination of two, three or more drugs is given. 
Chemotherapy can cause side effects. The side effects will depend on which drug (or 
combination of drugs) is used. There are now very good ways of preventing or reducing the side 
effects of chemotherapy. 
Hormonal therapy 
 Hormonal therapies work by altering the levels of particular hormones in the body. Some 
cancers depend on certain hormones in order to divide and grow. By altering the level of 
hormones in the body, or blocking the hormones from attaching to the cancer cells the cancer can 
be controlled. 
Drugs Used In Cancer Chemotherapy 10 
The main anticancer drugs can be divided into the following general categories 
The mechanism of action of these drugs is discussed below they include: 
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• Alkylating agents and related compounds, which act by forming covalent bonds with DNA 
and thus impeding replication. 
• Antimetabolites, which block or subvert one or more of the metabolic pathways involved in 
DNA synthesis. 
• Cytotoxic antibiotics, which is substances of microbial origin that prevent mammalian cell 
division. 
• Plant derivatives (vinca alkaloids, taxanes, campothecins) -most of these specifically affect 
microtubule function and hence the formation of the mitotic spindle. 
 Hormones, of which the most important are steroids, namely glucocorticoids, oestrogens and 
androgens, as well as drugs that suppress hormone secretion or antagonise hormone action. 
Side Effects of Chemotherapy 
Because the main target of chemotherapeutic drug is cell division, they will affect all 
rapidly dividing normal tissues, and thus they are likely to produce, to a greater or lesser extent, 
the following general toxic effects: 
• Bone marrow toxicity (myelosuppression) with decreased leucocytes production and thus 
decreased resistance to infection 
• Impaired wound healing 
• Loss of hair (alopecia) 
• Damage to gastrointestinal epithelium 
• Depression of growth in children 
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• Sterility 
• Teratogenicity. 
 
1.11 Herbal Medicine 
The term herb suggests something that is beneficial and has little potential for harm. We 
have been successfully using herb since ancient times. 
Over the centuries, the use of herbs becomes more complex. The first herbal medicine 
was simply the roots, leaves and flowers of plants. Then in 19th century we began to study the 
plants and identify their constituents. Researchers discovered that some of theses isolated 
constituents were very powerful medicine. The evolution of herbs into drugs continued into the 
20th century .Many wonderful and useful drugs emerged like antibiotics and powerful pain 
killers. Today people are discovering how well herbs work and have few side effects they have. 
As a result of this new interest herbal and pharmaceutical companies are isolating components of 
herbs. The herbal medicine is the most ancient form of health care known to human kind. Herbs 
have been used in all cultures throughout history. 
Herbal Medicine and Cancer  
               Patients confronting a diagnosis of advanced (stage4) cancer face the statistical reality 
that conventional chemotherapy can affect a cure for only a tiny minority of all such cases. More 
often than not, the reasonable impulse of these patients to investigate alternative treatment 
options such as herbal medicine is met with negative responses from oncologists. As a result, 
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consumer-patients challenged with cancer seeking herbal medicine resources may resort to 
unreliable products promoted on the Internet or via multilevel marketing that offer dubious 
herbal “cures.” Patients may also be less willing to disclose any use of these products to their 
physicians. Nurses as is often the case have the special challenge of being “between” both sides 
of this equation. The emerging integrative model of cancer treatment recognizes the importance 
of botanical medicine. However, despite extensive positive research data from experimental and 
preclinical studies, and the anecdotal clinical experience of many practitioners, patients, and 
cancer survivors, its potential in this field remains largely untapped and large scale clinical trials 
are generally unavailable. The reasons for this are multifactorial, and include historical, political, 
and cultural factors–and almost invariably a misunderstanding of the core principles of herbal 
medicine itself. 
The use of herbs for medical benefit has played an important role in nearly every culture 
on earth. Herbal medicine was practiced by ancient cultures in Asia, Africa, Europe and the 
Americas. The recent popularity in use of herbals can be tied to the belief that herbs can provide 
some benefit over and above allopathic medicine and allow users to feel that they have some 
control in their choice of medications. The widespread use of herbs, either directly or as dietary 
supplements, has raised many scientific questions. Herbal products may act in a pathway similar 
to pharmaceuticals yet without side effects. Natural anti-inflammatory compounds abound in the 
herbal world and are found in green tea, the spices turmeric and rosemary, and others. Because 
the use of non steroidal anti-inflammatory drugs (NSAID) is associated with a reduced risk for 
                                                                                                                                                    Introduction 
 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52                                                        21 
 
several cancers, it is at least plausible that natural NSAID should be explored for possible use as 
cancer preventives. 
            An important but often overlooked distinction exists between herbal medicines, (the 
practice) and herbal medicines (the plant-based remedies used in the practice of herbal 
medicine). The current trend of presenting so-called “scientific information” about herbs 
divorced from the context of herbal medicine that describes their medical use is rather like 
presuming that knowledge of needles will provide an understanding of acupuncture.  
           Chemopreventive agents are dietary ingredients which, being food derived, are considered 
pharmacologically safe. These ingredients contain bioactive molecules such as organosulfur 
compounds from garlic, polyphenols from green tea, and curcumin from turmeric, which exert 
the chemopreventive influences. For herbalists, the ultimate difference between food and 
medicine is basically one of intention. Herbalists have long used extractive techniques to 
concentrate the medicinal qualities of plants; by applying these time-tested methods to 
chemopreventive agents, these are transformed into therapeutic tools with anticancer activity. 
The same compounds, when intentionally deployed by practitioners as botanical medicine, 
transform prevention into treatment.15  
There is a rapidly growing literature base on how plant-derived chemo preventive 
compounds have a potential role in the treatment of cancer.16, 17 some of the more common 
chemo preventive compounds derived from dietary ingredients are listed below. 
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Chemopreventive plant compounds affect all phases of the cancer process (i.e. tumor 
initiation, promotion, and progression). Modern research is confirming that many chemo 
preventive dietary compounds are active at precisely the molecular targets that scientists seek to 
affect with the newer generation “targeted” biological response modifier drugs, typically the 
monoclonal antibody agents.  
1.13 Plant Aloe Vera 
History 
The several thousand years’ history of Aloe vera plant is a fascinating and captivating as 
a best seller historical novel. Long know for its legendry therapeutic properties, it was considered 
by some civilizations as the God. The curative virtues of the aloe are already known during 
ancient times. Authentic facts, testimonial and legendary narrations recount its history. 
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In the Bible, the spices is frequently cited as being used in herbal medicine since the 
beginning  of the first century AD, because it is mentioned in the New Testament (John 19:39-
40) and there came also Nicodemus, which at the first  came to Jesus by night and brought a 
mixture of myrrh and aloe. Aloe vera also known as the medicinal plant is a species of succulent 
plant that probably originated in North America. 
"If Aloe vera was to be discovered today, and its remarkable healing properties 
investigated, it would be hailed as the "wonder drug of this century". Aloe vera, on the other 
hand, has always been a natural product in whatever forms it has been used. Derived directly 
from the plant's leaves, Aloe vera is so effective in its natural state that no compelling reason has 
been found to spend the time and the enormous sums of money necessary to develop a synthetic 
version. It is hardly  surprising then, that the wonder plant, Aloe vera, might spring from this 
tradition of using natural botanicals. Since 1979, Aloe vera has been the subject of increasing, 
vigorous, scientifically based investigations. Aloe vera (L) a number of families Lilliaceae is a 
popular perennial succulent plant. 
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Aloe vera is a semi tropical plant. There are over 250 species of Aloe grown around the 
world. It contains more than two hundred tonic ingredients including essential amino acids, 
minerals, vitamins, enzymes and steroids. Also contains the most essential components required 
by the human body. It is grown wild in hedge-rows in dry soil conditions and almost all parts of 
India. It can be grown even under constant drought conditions. Commercial cultivation and 
utilization of this plant with the application of technology can be of great value. Aloe vera is a 
succulent prickly plant of the Lily Family which grows in warm, frost-free climates and which 
has been known for centuries as a potent medicinal plant according the “folk medicines” of 
cultures around the world. Scientific and medical research teams have investigated Aloe in many 
countries but especially in the United States and Japan. Much of this research is of high quality, 
which underlines the considerable status that Aloe has attained as a herb with well proven 
medical attributes. At the same time one should call into question any claims for Aloe vera (or 
any other substance) for which there may be a lack of enough medical evidence.  
1.14 The Elixir Reputation of Aloe 
The complaints that Aloe has been shown to address, with varying degrees of scientific 
backing include: Acne, dermatitis, abrasions, boils, carbuncles, cuts, hair loss, headache, high 
blood pressure, indigestion, nausea, peptic ulcers, duodenal ulcers, colic, ulcerative colitis, gum 
sores, other mouth disease, pruritis, burns, AIDS, atherosclerosis and coronary heart disease 
cancers, diabetes, allergies, colds, parasites - e.g. protozoan infections, viral infections, infections 
generally, constipation, dandruff, oedema, chronic fatigue syndrome, genital herpes, gingivitis, 
haemorrhoids, herpes simplex and zoster, inflammation, insomnia, insect bites including bee 
stings, jelly-fish stings, menstrual cramps and period irregularity, radiation burns, rashes, 
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oesophagitis, sprains, seborrhoea, sunburn, tendonitis, leg ulcers, ulcerations generally, vaginitis, 
varicose veins, arthritis, gout, rheumatism, Candida infection, other fungal infections, dandruff, 
psoriasis, warts. 
1.15 A Receptor for Aloe vera 
It has been well established that the Insulin-like Growth Factor II (IGF-II) and mannose-
6-phosphate (M-6-P) bind to the same receptor on the fibroblast. These two ligands bind at 
separate binding sites within the IGF-II/M-6-P receptor. However, the exact effect of these 
ligands binding to their individual binding sites is still unclear. One possible theory is that  
the binding of either ligand is capable of activating fibroblast proliferation. This would indicate 
that free M-6-P is a growth substance capable of yielding the same response as IGF-II. In Aloe, 
M-6-P is located at the end of the polysaccharide chain that fits into the receptor. This may be 
important in understanding how Aloe heals wounds and inhibits inflammation. It has been 
demonstrated that M-6-P improves wound healing in a straight line, dose-response fashion when 
compared with controls. For example, Glucose-6-phosphate, 
When used as a control, does not activate the receptor in the fibroblast. The binding site 
for this glucose is at the other end of the polysaccharide chain of Aloe and is probably a weak to 
moderate covalent bond. Lack of response by this control indicates that M-6-P is specific to the 
receptor. This may be important in understanding how Aloe heals wounds and inhibits 
inflammation. 
The receptor dynamics are part of the overall Aloe vera conductor-orchestra theory. One 
exciting characteristic of this theory is that the conductor-orchestra unit has little or no toxicity at 
very high gm/kg doses. Most of us working with Aloe vera have recorded no toxicity. In fact, we 
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feel that Aloe vera can modulate, reduce and may even eliminate toxicity of other biological 
agents. 
 
 
1.16 Aloe vera is a Biological Vehicle 
Compounds that are poorly absorbed through the stratum corneum of the skin need a 
vehicle to aid them in penetration. Glucocorticoids and vitamin C are not absorbed well and, as a 
result, most of the material is wasted when applied topically. A vehicle must be found that 
solubilizes steroids and Vitamin C while at the same time hydrates the stratum corneum. As 
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previously mentioned. Aloe vera’s antiinflammatory; wound healing and analgesic properties 
make Aloe a “biological vehicle” that helps to nullify the detrimental activity of glucocorticoids  
but at the same time aids the penetration. Similarly, vitamin C is not readily absorbed by the 
tissue. However, vitamin C has been shown to help in the synthesis of collagen, since it may 
counterbalance the collagen breakdown to reduce the development of autoantibodies. In certain 
diseases, such as rheumatoid arthritis, the levels of vitamin C are low. Our data, thus far, 
suggests that Aloe vera aids in the absorption of vitamin C and adds to its biological activity. 
Although all the factors that control the absorption of vitamin C are not know, previous studies 
show esterifying ascorbic acid increases the availability to tissues so that the therapeutic dose can 
be reduced. In a similar manner, Aloe vera’s activity as a biological vehicle to increase the 
absorption of vitamin C may be just as possible. 
Aloe vera can solubilize water soluble compounds as well as lipid soluble substances. 
Also, it can hydrate the stratum corneum cell membranes to aid a range of materials in 
penetrating the skin. The biological activity of Aloe can add and even synergize with many 
agents in producing therapeutic effects so that we call Aloe vera a “biological vehicle.” 
1.17 Cold versus Heat Processing Methods 
Data suggest that the time interval between leaf harvesting and processing (sun exposure) 
should be minimized (less than 24 hrs); heat exposure during processing should be minimized, 
especially if high temperatures are maintained for an hour or more. The whole leaf method can 
produce an Aloe extract which is high in total solids, high in retained high dalton (molecular 
weight) polysaccharides and glycosides with their scientifically demonstrated benefits, 
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Advantages of the Whole Leaf Cold Processing Methods 
 Advantages of the whole leaf, cold-processed, approaches include the following: 
1. Maximizes the yield of desirable constituents. 
2. Increases cost effectiveness of processing.  
3. Increased total solids concentration.  
4. Increased polysaccharide concentrations. 
5. Virtual absence of undesirable anthraquinones. 
6. Improved desirable characteristics for cosmetic usage.  
7. Increased concentration in permeability factors increasing transdermal penetration.  
8. Improved taste palatability.  
9. Increased concentration of growth factors responsible for accelerating of healing.  
10. Increased concentration of factors responsible for the stimulation of the immune system.  
 
1.19 Immune System 
 
There are several mechanisms which contribute to the immunological protection enjoyed 
by normal persons. Among these mechanisms the ingestion of bacteria and other potentially 
harmful agents by certain white blood cells (a process termed phagocytosis) and the formation of 
antibodies (formed by another group of white cells, the beta-lymphocytes) is probably the most 
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important. Scientific evidence suggests that Aloe gel contains substances which are active both 
in stimulating phagocytosis as well as stimulating the formation of antibodies. 
In one study, the Aloe fractions were shown to increase phagocytosis when injected into 
guinea pigs. In another study, mice were injected intraperitoneally with Escherichia coli, which 
caused a serious infection to develop in the abdominal cavity, namely, peritonitis. Injects of 
materials from two species of Aloe (Aloe barteri and Aloe ferox) both stimulated phagocytic 
activity in the animals. It was demonstrated that phagocytic activity was depressed in adult 
patients with bronchial asthma. A mixture of amino acids derived from Aloe enhanced the 
depressed phagocytic function of the white blood cells in these asthma patients. In an additional 
study when certain materials (lectins) purified from Aloe were added to human lymphocytes 
raised in tissue cultures, the human white cells were stimulated to produce antibodies. 
Perhaps the most remarkable studies concern the effect of Aloe fractions on the status of 
patients with HIV which causes AIDS. The polysaccharide fraction of Aloe was shown to exhibit 
antiviral activity and enhances cell function. The polysaccharide was given orally, 250 
milligrams four times a day, to 8 patients with ARC (AIDS Related Complex), with Walter Reed 
staging from 3 to 6. Eight of eight patients showed improvement within 90 days of therapy with 
an average reduction of 2 Walter Reed stages. Fever and night sweats were eliminated in all 
patients; diarrhea was alleviated in two of three patients, and opportunistic infections (which are 
usually responsible for the death of the AIDS patient) were controlled or eliminated in six of 
eight patients. Two patients, unemployable because of the intensity of their symptoms, returned 
to full employment. Three of three patients showed a decline in HIV core antigen (P-24). 
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Initially positive HIV cultures became negative in three patients. Clinical toxicity and side-
effects were entirely absent. Acute toxicity studies in animals showed no toxicity whatever at 
dosages 100 times those used in the pilot human experiments. These experiments however, were 
uncontrolled, and additional studies, utilizing appropriate scientific study design would need to 
be done before the data would be acceptable to the scientific community. 
In plasma there are four interacting systems which serve vital protective functions. These 
include the following: 
1. Intrinsic coagulation (blood clotting). 
2. Plasminogen(prevention and dissolving of intravascular clots). 
3. Kinninogen (inflammation). 
4. Complement (destruction of intravascular bacteria). 
The latter system, the complement system, consists of a series of proteins which require 
activation. When activated these proteins interact sequentially - a cascade phenomenon - and 
form circular, doughnut-shaped proteins, which are inserted into the surface membranes of 
bacteria, literally causing “holes” which permit the interior of the bacterium to become exposed 
to the environment, causing the death of the organism. Normally this complement system is 
stimulated by the presence of polysaccharides on the surface of the invading organism. Studies 
have shown that the polysaccharides (glucomannans) of Aloe can perform this function. 
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3. REVIEW OF LITRATURE 
 
 
Larry N. Tumlinson17 et al (1985), Study the methods and apparatus for extraction 
of aloe vera gel .the harvested leaves of aloe vera plants are positioned between a pair 
of endless moving belts for passing by a plurality of crushing rollers arranged in 
desired pattern.the crused leaves and extruded gel is than deposited on a drain grate to 
enable gravity flow separation the gel from the crused leaves. the drainage grate is 
sloped in order that the leaves will slowly moves across the drain grate to enable 
separation the gel while removing the leave from the gel collection area prior to the 
flowing of the contaminate aloin  from the leaves .  
 
Beatriz Varquez13 et al (1996), Studied the antiinflamatory activity of extract from 
alore vera gel, also studied the effect of aquous, chloroform and ethanol extracts of 
aloe vera gel on carrageenan induced edema in the rat paw and neutrophil migration 
into the peritoneal cavity stimulated by carrageenan. It also given the statement the 
capacity of the aquous extract to onhibit the cyclooxygenase activity. The anti 
inflammatory agents indomethacin and dexamethasone also decreased carrageenan 
edema and nutrophil migration. In the chloroform extract the chemical test performed 
by sterol type and anthraquinones were positive, these reault demonstrated that 
extract of aloe vera gel have an anti inflammatory action on the arachidonic acid 
pathways via cyclooxygenase. 
 
Gowri chandrakasan5 et al (1996) studied the influence of aloe vera on the healing 
of dermal wounds in diabetic rats. Full thickness excision/ incision wounds were 
geated on the back of rates and treated either by topical application on the wound 
surface or by oral adminisation of aloe vera gel to the rats. Full thickness excision / 
incision wounds were greated on the back of rates and treated  either by topical 
application on the  wound surface or by oral administration of aloe vera gel to therate 
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the result indiciate that aloe vera treatment of wounds in diabetic rates may enhance 
the process ofwound healing by influencing phase such as inflammation , fibroplasia 
ete. 
 
Rob Fletcher12 et al (1997) The analysis of the papers on Aloe Vera plant mention 
over time was completed by using agricda database 1970-1996.the study represents 
the reference listed below are from the biological abstract 1988-2000, and courtesy of 
silver platter information and more information is available from web 
http;/www.silverplatter.com. 
 
H.Avila6 et al (1997) studied cytotoxicity of a low molecular Weight fraction from 
aloe vera gel. Cytotoxicity of low moleqular fraction of aloe vera jel was determined 
by two different assays. Firstly exposure of monolayer of chicken fibroblast to 
induced LMWF to induced disruption of intracellular junctions and detachment of 
individual cell from bottom of the flask, with formation of cell free gaps in the 
monolayer. Secondly LMWF inhibited the production of reactive oxygen species by 
human polymorphonuclear leukocyte stimulated by Zymosan. This result conforms 
that aloe vera gel contains toxic low molecular wt. compounds. 
 
C.T. Ramachand15  et al (1997), Studied the processing of aloe vera leaf gel: A 
review proper scientific investigation on aloe vera have gained more attaintion over 
the last decade due to reputable, medicinal pharmaceutical and food property. Present 
processing technique aims at producing best quality aloe vera product but end aloe 
product contains very little or virtually no active ingredient. Hence appropriate 
processing techniques should be employed during processing in order to extend the 
use of aloe vera gel. 
 
Nobuycki Okamiura21 et al (1997), Three new chromone components were isolated 
from the gel of Aloe leaf. The structures of these compounds, which we have named 
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8-C-glucosyl-(S)-aloesol, 8-C-glucosyl-7-0-methylaloediol and isorabai-chromone, 
were shown to be 8-C-8-D-glucopyranosyl-2[(S)-2-hydroxy]propyl-7-hydroxy-5- 
 
methylchromone(8Cglucosyl(S)aloesol),8CDglucopyranosyl2(1’,2’dihydroxylpropyl
7methoxy5methylchromone(8Cglucosyl7Omethylaloediol)and8CBD[2’0(E3caffeoyl]
glucopyranosyl-2-[(~-2-hydroxy]propyl-7-methoxy-%methylchromone,respectively 
(isorabaichromone), by spectroscopic methods. 
 
T. Reynolds23 et al (1999).This review has largely upheld the therapeutic claims 
made in the earlier papers and indeed extended them into other areas. Treatment of 
inflammation is still the key effect for most type of healing but it is now realized that 
this is a complex process and that many of its constituent processes may be addressed 
in different ways by different gel constituent. Several reputable suppliers produce a 
stabilized aloe gel for use as itself or in formulations and there may be moves towards 
isolating and eventually providing verified active ingredients in dosable quantities.  
 
Ni; Yawei22 et al (1999), The inventions disclosed here in relate to composition for 
the sustained release of pharmacological agent compricing  aloe pectins having the 
combination of both a high molecular weight and a low degree of methoxylation .aloe 
pectin having at least one of the following properties; degree of methylation of less 
than about 50% by moles; rhamnose content of from about 2 to about 50% by mole 
;3-0-methyl rhamnose content of from about 0.1 to 5% by mole and capable of 
forming a gel in the presence of solution of a calcium salt .the aloe pectin are isolated 
from the leaves of a aloe by extraction ,where in the extraction is a accomplished by 
the supercritical fluid, water soluble organic solvent ,an acid ,an alkali, a chelating 
agent ,a bacteria,an enzyme and or combination thereof . according to the present 
invention ,pectins from gel and rind cell wall fibers of aloe vera extracted ,isolated 
and identified aloe pectins from pulp exhibit an off – white powder colour  and 
produced clear solution when dissolved in water. 
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Kathi J. Kemper11 et al (1999) Studied details about Aloe Vera plant and its 
proposed uses were topical treatment of  burns, abration and canker sore ; laxative 
affect etc, and there other proposed use were experimental treatment of ulcers, cancer 
and HIV; immunostimulant. They state that aloe first gained popularity in united state 
in1930’s with in the reports of its sources in treating X-ray burn and it has been 
boosted by claims that it has boosted by clams that it has been similar anti-aging 
effect to vitamin A derivative. Biochemistry of aloe also has been studied which gives 
details about chemical constituent in plant.  
 
Teresa Pecere16 et al (2000), Studied the aloe- emodine is new type of anticancer 
agent with selective activity against nuroectodermal tumors. Aloe- emodine is a 
hydroxianthraqunone present in aloe vera leaves, has a specific in vitro and in vivo 
anti nuroectodermal tumor activity. The growth of human neuroectodermal tumor is 
inhibited in mice with severe combined immunodeficiency without any appreciable 
toxic effect on the animals. Takinig into a account its unique cytotoxicity profile and 
made of action, AE might represent a conceptually new lead anti-tumor drug. 
 
Nathona Chaiyakunapruk9 et al (2005), Studied the efficacy of aloe vera used for 
burn and wound healing: A systemic review. Aloe vera has been tradionally used for 
burn healing but clinical evidence remains unclear. Author conducted a systemic 
reiew to determine the efficiency of topical aloe vera for the treatment of burn wound; 
four studies with the total of 371 patients were included in this report based on the 
Meta analysis using duration of wound healing as an outcome measure. Well 
designed trial with sufficient details of the contents of aloe vera product should be 
carried out to determine the effectiveness of aloe vera.  
  
 Ayse Can1 et al (2004), Studied the effect of aloe vera leaf gel and pulp extract on 
the liver in type 2 diabetic rate models. Diabetes rate were separated into four groups 
and each group was given by 15 d PBS solution pulp extract, leaf gel extract, 
glibendamide liver tissue were examined histologically  and it was conducted that 
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aloe gel extract has a protective effect compare to glibendamide against 
hepetotoxicity produced by diabetes if used in the treatment type 2 diabetes.  
 
 
Christian Rabe10 et al (2005) Studied acute hepatitis induced by an aloe vera 
preparation: A case report. Aloe vera plant extract is widely used in phytomedicine. 
The first cause of the acute hepatitis due to this compound was described. He 
concludes that Hepatitis in a57 year old female could be linked to the ingestion of 
aloe vera compound. The patient’s hepatitis resolved completely after discounting 
this by medicines.  
 
Taiwo V.O19 et al (2005), Consumption of Aqueous Extract of Raw Aloe Vera 
Leaves:Histopathological and Biochemical Studies in Rat and Tilapia. Forty-five 
juvenile tilapia and 30 weanling albino rats exposed to water containing 50, 100 and 
150ppm of aqueous extract of Aloe vera leaves for 96 hours and 28 days, respectively 
were used for this study. Fifteen tilapia and 10 rats exposed to clean water (0 ppm A. 
vera) served as controls. Clinical signs, mortality, gross and histologic organ 
pathology in the tilapia; weekly haematology, plasma biochemical parameters and 
organ pathology were monitored in the rats. Fish cultured in water containing A. vera 
exhibited erratic swimming patterns, rapid opercular movements, skin depigmentation 
and died within 24-96 hours. Gross and histologic tissue lesions in the test fish 
include skin depigmentation, pale and shriveled gills, dull, opaque and sunken eyes, 
stunting and clubbing of gill filaments, vacuolar degeneration and necrosis of gill 
epithelial cells, hyaline degeneration and necrosis of myofibrils, calcification of vasa 
vasori, hepatocellular vacuolar degeneration and necrosis. Haematologic and plasma 
biochemical changes in test rats include moderate to severe normocytic 
normochromic anaemia, hypoproteinaemia, increased AST levels, and decreased 
cholesterol and triglyceride levels. Gross and histologic tissue lesions include mild to 
moderate pulmonary congestion, flabbiness of the heart, hepatomegaly, mottling of 
kidneys, vacuolar degeneration and necrosis of hepatocytes, Kupffer cell hyperplasia, 
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periportal fibrosis, glomerular and tubular degeneration and necrosis, matting and 
clubbing of small intestinal villi, catarrhal enteritis and goblet cell hyperplasia. The 
severity of these changes increased with increasing concentrations of A. vera. No 
mortality, gross or histologic changes were observed in both control fish and rats. 
Results from this study show that consumption of water containing extracts of raw A. 
vera is very toxic to fish and rats. The serious health implication for human 
consumption of raw A. vera is discussed. 
 
Katrin Lachenmeier20 et al (2005) Studied the quality controle of aloe vera 
beverages .commercial material was reported to be frequently adulterated by artificial 
preservative or to lack significant amount of aloe ingredients .HPTLC and HS-SPME 
/GC/MS methods to acceses the authenticity of aloe vera beverages were developed 
in this study, aloin to differentiate between authentic and adulterated products .the 
HS-SPME method employed in this work allowed to detect the preservatives of 
benzic acid ,sorbic acid and pHB-esters .in 17 of 24 (71%) currently available of aloe 
food products an illegal addition of preservatives of up to 1000 mg /L could be 
ascertained but rather legal concerns ; controles have to be intensified to ensure the 
sufficient product quality with regards to preservatives.   
 
Etim OZ4 et al (2006) Studied the protective effect of aloe vera juie on lindane 
induced hepatotoxicity and cytotoxicity. Serum levels of hepatic enzyme markers. 
Glutamate pyruvate transamine glutamate oxaloacetate transaminase gama glutamyl 
transferase and alkaline phosphatase were determined after oral adminisation of 
aloevera leaves extract and lindane .the bend of polychromatic erythrocytes was also 
observed pretreatment with aloe vera leaves extract at concentration of 1.0 ml/ kg 
body weight significantly decresed the serum level. 
 
P. Dehdari7 et al (2006) Studied and demonstrated details about the aloe vera as 
semifinish  product like gel, powder and finish product like health drinks, also its 
cultivation ,benefit of aloe vera in medicine, its biochemistry, processing of plant into 
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gel and powder, its also gives commercial information, economical and world market 
report and its recommendation. 
 
 
Rana P. Singh8 et al (2006), Studied the mechanism of action of novel agent of 
prostate cancer chemoprevention. Despite the advantage in the understanding of Pca 
growth and development, it is still the leading cause of mortality due to cancer in 
men. In vivo preclinical study has indicated chemo preventive effect of many agents 
in Pca xenograft and transgenic mouse models. This review focuses on novel Pca 
chemo preventive observation in laboratory studies which could provide the rationale 
for the prospective use of chemo preventive agent. 
 
Rajendran A.2 et al (2007) Studied and demonstrated the separation and 
characterization of the phenolic anthraquinones from aloe vera. Among the different 
from of A.vera sap contains more phenolic anthraquinones of 7.09 mg/g of 
lyophiligate than the remaining from all the three form of aloe and chromatographed 
fraction of aloe sap in five different solvent mixtures were characterized by IR, 
Flurescence spectroscopy, Mass spectroscopy and U.V.specroscopy. 
 
Keivan Zandi3 et al (2007) An article entitled antiviral activity of aloe vera against 
herpes simplex virus type 2: An in vitro study.herpes simplex virus type 2 is an 
enveloped virus which causes genitel herpes and some other complication finding a 
new natural anti –HSV-2 drug has been a subject of interest for scientist because of 
severe side effect and a development of some resistance mutants of this virus 
regarding the several enviormental factors affecting the chemical and biological 
composition of aloe vera ,it is tried to evaluate anti- HSV-2 activity of this plant. 
 
Mike Adamas14 et al (2007), Studied and given details about the aloe vera as 
miracle: a natural medicine for cancer cholesterol dibetes, inflammation, IBS and 
other health conditions. It involves details about aloe vera boost immune function and 
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destroys cancer tumors, aloe vera halts inflammation,aloe vera inhances skin health, 
stabilizes blood sugar in dibetis, it also lowers cholesterol and triglycerides, also 
relives joint and muscle pain, amplifies the anti oxidant effect of vitamins and aloe 
vera heals radiation burns from radiation cancer treatments. 
  
R. M. Coopoosamy18 et al (2007), Studied the Traditional use, antibacterial activity 
and antifungal activity of crude extract of Aloe excelsa. The fleshy leaves and roots of 
most species within the Aloe family are used in many traditional treatments 
(Mabberley, 1987). Traditional healers and indigenous people utilize mainly the leaf 
sap of this genus widely for the treatment of wounds, burns, rashes, itches, cracked 
lips and cracked skin (Cera et al., 1980). Antimicrobial activities on the crude extract 
of Aloe exclesa was carried out in attempts to validate the use by traditional healers in 
the use of there latex and gel exudates for various medicinal ailments. 
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                            6. List of materials and instruments 
                             
 
           Methanol                   Qualigens fine chemicals, Mumbai 
 
           PHA                     Gibco Invitrogen  Corporation 
 
        Giemsa stain                   Qualigens fine chemicals, Mumbai 
 
        Fetal calf serum                 Gibco, Invitrogen Corporation 
      Eagles MEM Media                 Gibco, Invitrogen Corporation 
       Doxorubicin HCl                                      United Biotech Pvt Ltd, Bagbania 
       Docetaxel trihydrate                                  Dr Reddys Lab Ltd 
      Potassium chloride                  Rankem, New Delhi 
       Acetic acid                    Merck Ltd, Mumbai 
        Ethanol        Bangal Chemicals and Pharmaceuticals Ltd, Kolkata 
 
      Normal saline                   Claris Life Science Germany Ltd, Mumbai 
 
    Phosphate buffer                         Merck Ltd, Mumbai 
 
    Centrifuge                Remi, Mumbai 
 
    Water bath                 Remi, Mumbai 
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     Incubator                        Remi, Mumbai 
 
      Cyclomixer                       Remi, Mumbai 
 
     Balance                       Sartorius, Japan 
 
        Trinocular microscope                                Olympus, Japan 
    (Flourescent – CH201) 
        
        Laminar air flow           SM. Scientific Instrument Pvt. Ltd., Delhi 
 
      CO2 incubator                            Hera cells, Heraeus 
 
     Inverted microscope                            Olympus, Japan 
             (CKX41) 
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7. METHODOLOGY 
 
 
 
7.1 Sample Collection  
 
Plant Aloe vera was collected from cultivated area on well fertilized soil and healthy, 
matured plant has been selected for studies. Plant has selected from Tindal, Erode 
district, and Perumanallur, Coimbatore district. 
 
 
7.2 Sample Identification 
 
Specimen of aloe vera (L.) was harvested and collected plant has been identified by 
Botanical survey of India at Coimbatore. Fresh leaves of the cultivated plant were 
used in these studies. 
 
 
7.3 Processing of Sample  
 
 Harvesting- the healthy and matured Aloe vera sample plant has been selected from 
the farming land. Maturity of the plant should be noticed.    
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7.4 Washing and cutting  
 
The harvested aloe vera plant’s leaves has been cutted from the base in to single 
single leaf, then leaves were washed under running tab water 2-3 times again with 
distilled water to remove dust particle from leaf surface, and finally with anti 
microbial solution, 60% alcohol to remove surface pathogens from the leaves .Then 
the washed leaves were processed for cutting. To cut and separate out the gel and leaf 
lining, outer layer sharp, sterile knife has been used17.  
 
 
              
 
Then the gel and skin of the leaf has been cutted in to small pieces in required 
quantity for the extraction. 
 
7.5 Extraction17 
 
Extraction of Aloe vera: 
 
A. vera leaves (big and healthy leaves) weighed, washed and cut in the middle, 
the gel were separated by scratching with a spoon. Aloe vera leaves pulp extract: the 
leaves pulp was cut in to the small pieces (514 gm) and homogenized with phosphate 
buffered saline solution (PBS; pH 7; 600 ml) by means of a blender. The extract was 
                                                                                                                          Methodology 
 
 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52                               50 
                           
 
kept at 4º C overnight, and then filtered through muslin cloth and the filtrate 
Centrifuged at 20000 rpm for 30 min. at 2 º C in a refrigerated centrifuged. The green 
pallet was discarded and the clear yellow supernatant was taken and lyophilized. thus 
10 gm of Aloe vera leaves pulp extract was obtained .the extract used in the 
experiment was (7.5%) prepared by dissolving the powder in PBS and mixing it 
thoroughly via magnetic stirrer.  
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Aloe vera leaf gel extract:  
 
The gel was homogenized in a blender, then diluted with an equal volume of PBS 
and homogenized for a second time and the extract was kept at 4º C overnight then 
filtered through cloth. The clear filtrate was kept and lyophilized at -20 ºC 
. 
 
7.6 Lyophilization: 
 
In the process of lyophilization, extract are subjected to extreme dehydration in 
the frozen state and than sealed in a vacuum. In this condition, desiccated 
(lyophilization) extract of plants contain its constituents viable for many years. The 
clear liquid filtrate after an overnight was lyophilized in deep refrigerator at -20 ºC. So 
there is a direct sublimation from liquid to solid state. And finally aloe vera was 
obtained in powder form. Which is further underpass by phytochemical tests to 
conform its constituents present or not.    
 
7.7 Preliminary Phytochemical tests:  
 
A. General test: 
 
1. Boil (100mg) of drug with 100 ml of distilled water and than add little amount of 
kieslghur and than filtered. 
 
 from the above filtered solution (5ml) add 0.2 gm borex and heat until dissolved, few 
drops of liquid into test tube nearly full of water was poured on it, green fluorescence 
appears.  
 
 Bromine test: add 2 ml of aloe solution into 2 ml of freshly prepared bromine 
solution. It gives pale yellow precipitate.  
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B. Specific test: 
 
1. Nitric acid test:  
 
 
Add 5 ml of aloe solution in to 2 ml of nitric acid, which gives brownish color, rapidly 
change green for cape aloe and deep brownish red color will change into green for aloe 
baridensis.  
 
 
2. Nitrous acid test;  
 
2 ml of aqueous solution of aloe, added into few small crystal of sodium nitrate and add 
little acetic acid, which gives red pink to caramine color (Barbados) and lesser pink by 
cape aloe. 
 
C. Klunge’s Isobarbaloin test:  
 
Add 20 ml aqueous solution of aloe into drops of saturated copper sulfate solution 
followed by 1 gm of sodium chloride and 10 ml of alcohol (90%), which gives wine red 
color and at least persist for ½ hours. In case of case aloe lesser coloration of wine-red 
color which rapidly feds to yellow color appears.    
 
D. Modified Bronstanger’s test:  
 
In 1 ml of the sample add few drops of ferric chloride and dilute Hcl were added which 
bring oxidative hydrolysis followed by CCl4, rose pink to cherry red color appears when 
the solution is shaken with dilute NH3. 
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7.8 Experimental work  
 
  In vitro cytotoxic activity 
 
 7.8.1 Cell culture21: 
Materials: To a 500 ml bottle of EMEM media, add 55.5 ml IFS (Inactivated fetal calf 
serum) to a final concentration of 10% and 5 ml Penicillin- Streptomycin to a final 
concentration of 1µg/ml strep. 
 
Serum Media: Add 10 ml Glutamine upon opening to 1 lt. 
T 75 flasks and pipettes. 
70% ethanol in a spray bottle. 
 
The Cell:  
Melanoma and fibro sarcoma 2 cell line that grows very quickly and is easily 
maintained. They are grown in EMEM media with fetal calf serum and antibiotics and 
maintained at 37°C or lower. Stocks will be grown in T75 flasks and will be split about 
every 3 day. Experiment will be done in 6 well plates.  
 
Sterile Technique:   
All cell culture were must be performed in the tissue culture hood, also known as 
biological safety cabinet. The hood protect from the aerosol contamination by filtering all 
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of airs that enters. In addition, to prevent other contamination, spray down all the inside 
working surfaces  of the hood with 70% ethanol and wipe the surface dry with wipe 
before and after using the hood. Set all the materials need in the hood before bringing in 
the cells such as the media and flasks, but also try not to clutter the hood with 
unnecessary items. In general work is to be done quickly with good sterile technique to 
avoid contamination.    
 
Procedure:  
 
Cell Culture for Melanoma cell. 
 
The B16F10 melanoma cell line was kindly provided by A.R. Lab Salem. Cells 
were cultured in Eagle's minimum essential medium (EMEM), supplemented with 10% 
fetal calf  serum (FCS) and streptomycin plus penicillin (100µg/ml and 100 IU/ml, 
respectively).Cells were cultured in a 5% CO2 humidified atmosphere at 37°C until near 
confluence.  All the processes were carried out in a vertical laminar flow chamber. 
 
Cell Culture for Sarcoma cell:  
 
The SW982 fibro Sarcoma cell line was kindly provided by A.R. Lab Salem. 
Cells were cultured in Eagle's minimum essential medium (EMEM), supplemented with 
10% fetal calf serum  
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(FCS) and streptomycin plus penicillin (100µg/ml and 100 IU/ml, respectively).Cells 
were cultured in a 5% CO2 humidified atmosphere at 37°C until near confluence.  All the 
processes were carried out in a vertical laminar flow chamber. 
 
Procedure: 
Volume:  Start culture at 25 million cells in 12 ml media in T75 flask. 
Duration:  culture was grown for 3 days and than split.  
1. Tap the flasks to loosen cells from the surface. If cells are not resuspended well by 
tapping, remove cells with scraper. These cells are not very adherent, so they will lift off 
the surface fairly easily.  
2. Pipette up and down 10X to create a cell suspension. 
3. Count of cells with a hemocytometer. 
4. Resuspend cells to appropriate density and seed in flasks.  
  
7.9 Drug treatment: 
 
B16F10 Melanoma cell:  
Aloe vera extracts were prepared in increasing final concentrations, ranging from 
25 to 200µg/ml. The drug extracts were treated with plates containing confluent 
monolayer of B16F10 melanoma cell lines. Negative control group was melanoma cell 
line only, and the positive control group was treated with doxorubicin (0.032µg/ml). 
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After incubating for 24 hrs at 37˚C, the cells were trypsinized (0.25% in PBS) and then 
centrifuged at 1000 rpm for 5 min, washed twice with fresh medium, and resuspended 
with fresh medium. Cell viability was counted for each concentrations of crude extract as 
well as for control. 
 
SW982 fibro sarcoma cell: 
 
Aloe vera extracts were prepared in increasing final concentrations, ranging from 
25 to 250µg/ml. The drug extracts were treated with plates containing confluent 
monolayer of Sarcoma cell lines. Negative control group was sarcoma cell line only, and 
the positive control group was treated with doxorubicin (0.032µg/ml). After incubating 
for 24 h at 37˚C, the cells were trypsinized (0.25% in PBS) and then centrifuged at 1000 
rpm for 5 min, washed twice with fresh medium, and resuspended with fresh medium. 
Cell viability was counted for each concentrations of crude extract as well as for control. 
 
Aloe vera sample drug dilutions: 
 
 For melanoma cell line extract has been made from ranges 25 to 200 µg/ml as 
followed by dilution procedure –  
100 mg aloe extract dissolved in 100 ml of PBS solution to produce 1000 µg/ml, from 
this solution different dilution has been made as shown below  
• 25µg/ml, 0. 25 ml solution dissolved in 10 ml of stock solution. 
• 50 µg/ml, 0.5 ml solution dissolved in 10 ml of stock solution. 
• 100 µg/ml, 1 ml solution dissolved in 10 ml of stock solution. 
• 150 µg/ml, 1.5 ml solution dissolved in 10 ml of stock solution. 
• 200 µg/ml, 2 ml solution dissolved in 10 ml of stock solution. 
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 For Sarcoma cell line extract has been made from ranges 25 to 200µg/ml as 
followed by dilution procedure –  
 
100 mg aloe extract dissolved in 100 ml of PBS solution to produce 1000 µg/ml, from 
this solution different dilution has been made as shown below  
 
• 25 µg/ml, 0. 25 ml solution dissolved in 10 ml of stock solution. 
• 50 µg/ml, 0.5 ml solution dissolved in 10 ml of stock solution. 
• 100 µg/ml, 1 ml solution dissolved in 10 ml of stock solution. 
• 150 µg/ml, 1.5 ml solution dissolved in 10 ml of stock solution. 
• 200 µg/ml, 2 ml solution dissolved in 10 ml of stock solution. 
• 250 µg/ml, 2.5 ml solution dissolved in 10 ml of stock solution. 
 
Control Groups:  
  
 1. Positive control was treated with standard doxorubicin (0.032 µg/ml)/ 
 2. Negative control was only cancer cell lines. 
 
7.10 Trypan blue exclusion assay: growth and viability test21.  
 
Material: 
Hemocytometers 
Trypan blue diluted in required quantity with PBS. Store at room temperature. 
Hand held counters.  
 
Principle: - It is based on the principle that live cells possess intact cell membranes that 
exclude certain dyes, such as Trypan blue, Eosin or Propidium whereas dead cells do not. 
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Procedure:   
  
1. Prepare a uniform cell suspension as described below. 
Suggestion: Dilute cells 1:5 or 1:10 before counting. Dilute in media and take an initial 
aliquot of cells. (Smaller aliquot may be less uniform). 
 
2. Mix a small aliquot of cells 1:1 with trypan blue solution. (NOTE) - When 
counting cells for normal pass aging, trypan blue is not needed. Viable cells excluded 
trypan blue, while dead cell stain blue due to uptake of dye. 
  
3. Center a cover glass over the hemocytometer chambers. Fill one chamber with 
the cells using a Pasteur pipette. The solution will be entering the chamber by capillary 
action. Do not over fill. If the cell will spread in two lateral grooves adjoining the grid 
table, clean the hemocytometer and repeat the application.  
 
4. With an inverted microscope, count the cells located in to four corners and the 
center square of the hemocytometer, for a total of five squares. Using visualization of the 
cells. Use a hand held counter to record the number of cells counted. During the trypan 
blue exclusion assay don’t worry about calculating the percentage of viability of the cells. 
Simply generate total live cell count by only counting the circular white cells and not the 
blue cells. The total cell count should exceed 100 to be reliable. If after counting five 
squares, 100 cells have not yet counted then count additional squares. 
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5. The percentage of viable cells can be calculated by using the formula shown below. 
  
6. Wash cells off the hemocytometer with water. Spray some 70% EtOH and let dry.  
 
To evaluate growth and viability of the treated and untreated cells, the percentage 
of viable and non-viable cells was determined, using trypan blue exclusivity stain. Cell 
growth and viability was measured by adding 0.4% trypan blue in 0.9% saline to a 50% 
dilution, and cells were counted using the hemocytometer. Briefly, 0.5 ml of the trypan 
blue solution was transferred to a test tube and 0.3 ml of PBS plus 0.2 ml of the 
trypsinized cell suspension (dilution factor of 4) were added. The final solution was 
thoroughly and gently mixed and allowed to stand for 5 min. Then a drop of this dye-cell  
Suspension was loaded on to both chambers of the haemocytometer. Cells were 
examined and counted in duplicates under light microscope at 100 X (Olympus, Japan). 
Percentage cell viability was calculated by the formula: 
 
Cell viability =   No. of viable cells (unstained cells) x l00 
      Total no of cells 
(Stained and unstained) 
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5. PLAN OF WORK 
 
 
 
The present work was carried out to study in vitro cytotoxic activity of Aloe vera 
extract against B16F10 melanoma and SW982 sarcoma cell line. 
 
The following experimental protocol was designed to allow a systemic approach to study. 
 
Plant Processing: 
 
 
o Plant sample collection.  
 
 
o Processing of sample. 
 
 
o Extraction. 
 
 
o Phytochemical investigations 
 
 
 
 
 In vitro Cytotoxicity activity.   
 
 
o Procurement of cancer cell line. 
 
 
o Cell culture. 
 
  
o Trypan blue exclusion essay for cell viability. 
 
 
                                                                                                                          Plant Profile 
 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52                                        
 
 
 
31
2. PLANT PROFILE 
 
2.1 HISTORY 
 
As is often the case with so called 'miracle plants' their exaggerated reputation 
actually discredits them. Aloe vera is a truly wonderful plant with no shortage of 
members for its fan club. It has a very long and well established reputation as a healing 
plant, particularly for skin conditions, minor cuts and abrasions. The dried latex, which is 
not the same as the gel, but instead derives from the yellow juice contained in the 
pericyclic tubules of the inner leaf, is a well known laxative. 
Despite the fact that Aloe has been in documented use for at least 3500 years, 
controversial and contradictory information about this plant abounds. The earliest 
reference to its use can be found in the famous Egyptian Ebers Papyrus, which dates back 
to 1500 BC and is widely regarded as one of the earliest documents on what was to 
become the western Materia Medica. However, it is more than likely that it has been 
commonly used for centuries before it was recorded. In fact, it seems more likely that 
Aloe was such a commonly used plant, that earlier documents (of which few have 
survived) never even bothered to mention it. In the hot and dry countries of the 
Mediterranean and the Middle East Aloe vera served as a soothing household remedy for 
sunburns and moisturizing cosmetic lotion. 
More efficient processing methods have recently been developed that utilize the 
whole leaf and just remove the green parts of the leaf in a cold process involving a 
cellulose dissolving substance. This retains the biochemical activity of the Aloe vera Leaf 
in its integrity. The resulting gel is of a yellow color as it still retains the aloin, which is 
the bitter, laxative compound. Another whole leaf extraction method involves the same 
cold process leaf processing in the first step, but then utilizes short duration low 
temperature controlled sterilization techniques that kill off bacteria without the addition 
of chemicals. The resulting gel is then concentrated in a vacuum chamber and 
subsequently dehydrated into a water soluble compound that retains the biochemical 
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activity indefinitely without the addition of any preservatives. This method is currently 
regarded as the most efficient method, even though heat is used in the process.  
2.2 TAXONOMICAL FEATURE 
Kingdom          -                          Plantae 
 
Division           -                          Magnoliophyta 
 
Class                -                          Lilliopsida 
 
Order               -                          Asparagales 
 
Family              -                          Lliliaceae 
 
Genus               -                           Aloe 
 
            Species              -                         Aloe vera. 
 
 
2.3 COMMON NAME 
 
 
Bengali and sans.            -     Ghritakumari 
 
Hindi                               -     Ghee – kanwar 
 
Kannad                            -     Kolasoare 
 
Telagu                             -     Kalabanda 
 
Tamil                              -      Kathalai 
 
2.4 SYNONYMES 
 
Aloe barbedensis mill, Aloe indica royle , Aloe perfoliata L, Aloe vulgaris Lim, 
Indian Aloe, First Add Plant, Burn  Aloe, Miracle plant.  
 
2.5 BIOLOGICAL SOURCE 
 
Is Stemless and very short succulant plant, 60-100 cm tall, spreading by offsets. 
Aloe vera growing as ornamental plant. Aloe vera plant belongs to family Liliaceae. 
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2.6 MACROSCOPIC CHARCTERSTIC  
 
 
Color  
 
 Color peagreen, (when young spotted with white); bright yellow tubular flowers 
 
 
General appearance 
 
The gel is a viscous, colorless, transparent liquid. 
 
 
Organoleptic properties 
 
Viscous, colorless, odourless, taste slightly bitter. 
 
 
 Shape and Shape 
 
Leaves 30, 50 cm long and 10 cm broad at the base, bright yellow tubular flowers 25, 35 
cm in length arranged in a slender loose spike; stamens frequently project beyond the 
perianth tube. 
 
 
2.7 CHEMICAL CONSTITUENTS 
 
 
From the gel  
 
 
 Polysaccharide: glucomannan and acemannan.  
 
  
 Other : carboxy peptidase, Mg,Zn,Ca,glucose,cholesterol,salicylic acid,prostaglandin          
precursor,vitamin A,C,E, Saponins,amino acid.    
 
 
From leaf lining: 
 
Anthraquinone glycosides: aloin,aloe-emodin,barbaloin 
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2.8 Experimental Studies 
 
Aloe vera: Potential Clinical Benefits 
 
1. Cardiovascular: none 
 
 
2. Pulmonary: none 
 
 
3. Renal and electrolyte balance: none 
 
 
4. Gastrointestinal/hepatic: Stimulant laxative (leaf lining); gastric and duodenal ulcers    
(gel); inflammatory bowel disease (gel, experimental use) 
 
5. Neuropsychiatric: none 
 
 
6. Endocrine: Hypoglycemic (gel) 
 
 
7. Hematologic: none 
 
 
8. Rheumatologic: none 
 
 
9. Reproductive: Emmenagogue (leaf lining, traditional use) 
 
 
10. Immune modulation: Immunostimulant, anti-inflammatory (gel) 
 
 
11. Antimicrobial: Antibacterial, antiviral, antifungal (gel) 
 
 
12. Antineoplastic: Antitumor, attenuation of adverse effects of cancer therapies (gel) 
 
13. Antioxidant: none 
 
14. Skin and mucus membranes: Vulnerary (wound healing), psoriasis remedy (gel) 
 
15. Other/miscellaneous: none 
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2.9 PLANT PHOTOES  
 
                                                Cultivation on the farming soil.  
 
                          
  
                                                              
 
 
                                                              Plant with flowers. 
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8. Results and Discussion 
 
8.1 Processing of plant:  
 
The plant has collected and identified as Aloe barbidensis. 
 
8.2 Extraction: 
 
The extraction has done successfully by comparatively study of extraction 
procedure. Finally 765 mg Aloe extract was extracted with PBS solution by cold 
processing method. Liquid extract was than lyophilized at -20oc to get fine solid powder 
extract of Aloe vera. 
 
8.3 Phytochemical investigation: 
 
Lyophilized extract was than brought into phytochemical tests find to out its 
polysaccharides and glycosides constituents present or not in final extracted extract, 
which exhibits cytotoxicity to cancerous cells. 
 
This investigation exhibits that lyophilized extract retains its cytotoxic constituents in it.  
 
The present study was carried out to evaluate cytotoxic activity of Aloe vera 
leaves extract on the B16F10 melanoma cancer cell line and SW982 fibro sarcoma cell 
lines. 
8.4 Cytotoxic activity: 
 
Cytotoxic activity of above Aloe vera extracts was evaluated on the basis of “Trypan 
blue exclusion assay” for cell viability. 
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8.5 Cell viability: 
 
Cell viability can be defined as the number of healthy cells in a sample. The most 
straight forward method for determining viable cell number is a direct counting 
of the cells in a haemocytometer.  
 
Melanoma cell-To evaluate the cell viability of B16F10 melanoma cell line 
treated with aloe vera extract of the drug Aloe vera, groups were taken which are as 
follows: 
 
1. Control group –In this group out of 100 total cells 95±1.33 viable and 05±1.33 
non viable cells were found. 
2. Chemotherapy drug treated group - In this group out of 100 total cells 20±1.22 
viable and 80±1.22 non viable cells were found. 
3. Aloe Vera  extract treated group – This group is consisted of following 
subgroups:  
i)  25µg/ml extracts treatment - Out of 100 total cells 52±1.66 viable and 48±1.66 
non viable cells were found. 
ii) 50µg/ml extract treatment - Out of 100 total cells 46±2.03 viable and 54±2.03 non 
viable   cell were found. 
iii) 100µg/ml extracts treatment - Out of 100 total cells 38±1.39 viable and 62±1.39 
non viable   cells were found. 
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iv) 150µg/ml extracts treatment - Out of 100 total cells 29±2.11 viable and 
71±2.11non viable cells were found. 
v) 200µg/ml extracts treatment - Out of 100 total cells 22±1.95 viable and 78±1.95 
non viable cells were found. 
 
  Treatment of Aloe vera extracts against B16F10 melanoma cell line, in all concentration 
range showed decrease in percent cell viability, as compared to that of negative when 
examined by “Trypan blue exclusion assay”. In overall variation of test samples, Aloe 
vera extract showed its best activity in the conc. of 200µg/ml, which was approximately 
equal to the activity of standard drug doxorubicin. Therefore, we concluded from cell 
viability assay that extract with phosphate buffer exhibited very good cytotoxic activity 
as compared to that of positive control. Results are shown in Table no. 1.  
 
Sarcoma cell -  To evaluate the cell viability of SW982 fibro sarcoma cell lines. 
Treated with aloe vera extract of the drug Aloe vera, groups were taken which are as 
follows: 
 
1 Control group –In this group out of 100 total cells 96±1.21 viable and 04±1.21 
non viable cells were found. 
2 Chemotherapy drug treated group - In this group out of 100 total cells 21±1.01 
viable and 79±1.01 non viable cells were found. 
3 Aloe Vera  extract treated group – This group is consisted of following subgroups:  
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 i) 25µg/ml extracts treatment - Out of 100 total cells 50±1.31 viable and 50±1.31 
non viable cells were found. 
ii) 50µg/ml extract treatment - Out of 100 total cells 44±1.12 viable and 56±1.12 non 
viable   cell were found. 
iii) 100µg/ml extracts treatment - Out of 100 total cells 39±1.93 viable and 61±1.93 
non viable   cells were found. 
iv)     150µg/ml extracts treatment - Out of 100 total cells 34±1.20 viable and 66±1.20non 
viable cells were found. 
v) 200µg/ml extracts treatment - Out of 100 total cells 30±2.01 viable and 
70±2.01non viable cells were found. 
vi)      250µg/ml extracts treatment - Out of 100 total cells 27±1.01 viable and 73±1.01 
non viable cells were found. 
 
Treatment of Aloe vera extracts against, SW982 fibro sarcoma cell lines in all 
concentration range showed decrease in percent cell viability, as compared to that of 
negative when examined by “Trypan blue exclusion assay”. In overall variation of test 
samples, Aloe vera extract showed its best activity in the conc. of 250 µg/ml, which was 
approximately equal to the activity of standard drug doxorubicin. Therefore, we 
concluded from cell viability assay that aloe vera extract with phosphate buffer exhibited 
very good cytotoxic activity as compared to that of positive control. Results are shown in 
Table no. 2. 
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8.2 Table No.1 
 
 Effect of different concentration of Aloe vera extract on B16F10 melanoma cancer 
cell viability test- 
 
 
 
Drug conc. (µg/ml) 
 
 
 
Total cells 
 
Viable cells 
 
Nonviable cells 
 
Control 
 
100 
 
95±1.33 
 
5±1.33 
 
25 
 
100 
 
52±1.66 
 
48±1.66 
 
50 
 
100 
 
46±2.03 
 
54±2.03 
 
100 
 
100 
 
38±1.39 
 
62±1.39 
 
150 
 
100 
 
29±2.11 
 
71±2.11 
 
200 
 
100 
 
22±1.95 
 
78±1.95 
 
Doxorubicin(0.032) 
 
100 
 
20±1.22 
 
80±1.22 
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8.3 Table 2:  
 
Effect of different concentration of Aloe vera extract on SW982 fibrosarcoma cancer 
cell viability test- 
 
 
Drug conc. (µg/ml) 
 
Total cells 
 
Viable cells 
 
 
Nonviable cells 
 
Control 
 
 
100 
 
96±1.21 
 
4±1.21 
 
25 
 
 
100 
 
50±1.31 
 
50±1.31 
 
50 
 
100 
 
 
44±1.12 
 
56±1.12. 
 
100 
 
100 
 
39±1.93 
 
61±1.93 
 
150 
 
100 
 
34±1.20 
 
66±1.20 
 
200 
 
100 
 
30±2.01 
 
70±2.01 
              
             250 
              
             100 
         
        27±1.01 
         
           73±1.01 
 
Doxorubicin(0.032) 
 
100 
 
       21±1.01 
 
          79±1.01 
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Table-3.  
                                           Preliminary phytochemical tests: 
 
            
              Chemical test name 
                                                       
                           Result 
A. General test 
 
         Bromine test- 
         Nitric acid test- 
         Nitrous acid test- 
 
 
                              + ve 
                              + ve 
                              - ve 
       
B. Klunge’s isobarbaloin test- 
 
                              
                               - ve  
 
       C. Modified bronstanger’s test- 
                               
                               + ve 
 
       Fig No. 1-Effect of different conc. of Aloe vera on percent cell viability              
                                   Concentration Vs Percent viability 
 
0 50 100 150
Control
std
25 µg / ml
50 µg / ml
100 µg / ml
150 µg / ml
200 µg / ml
Control
std
25 µg / ml
50 µg / ml
100 µg / ml
150 µg / ml
200 µg / ml
% Cell Viability
.
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Fig.No.-2. Effect of aloe vera on difference concentration on SW980 Fibrosarcoma  
 cell. 
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                Photo - Showing “Trypan blue exclusion by non viable cells” 
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                            9. Summary and Conclusion 
Cancer is one of the most dangerous and dreadful disease of the 20th century and 
spreading further with continuance and increasing incidence in 21st century. An 
alternative solution to western medicine embodied with severe side effect is the use of 
medicinal plant preparation to arrest the disease. 
 
This piece of work is mechanized to prove potentiality of herbal extracts of Aloe 
vera to kill the cancerous cells and to protect the normal cells from the cytotoxic effect of 
anticancer drugs. Here the culture is being performed for B16F10 melanoma and SW982 
fibrosarcoma cancer cell, the molecular involvement and potency of chemotherapeutic 
drug in cancer cell is well presented.  
 
In vitro cytotoxic activity performed revealed that Aloe vera exhibited good 
cytotoxicity. The best cytotoxic activity by Aloe vera was shown at 200µg/ml 
concentration for B16F10 melanoma cell line and 250µg/ml for SW982 fibro sarcoma 
cancer cell as compared to that of standard anticancer drug.  
 
In future this piece of work can be mechanized for  purification and identification 
of active constituents present in Aloe vera by using various analytical techniques like thin 
layer chromatography, column chromatography, FT-IR, mass spectroscopy etc. Also, this 
work can be extended for in vivo study of antitumor activity by measuring tumor volume 
and also for in vivo cytoprotection activity. The statistical correlation can be established 
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on the above based information, so that this wonderful plant of  Aloe vera which is well 
known for its antispasmodic activity and used since long as “cosmetics product”, can be 
used as a drug of choice during cancer chemotherapy, which is available at low cost and 
is poor man friendly. In near future such products will be a boon to man kind for cancer 
and HIV patients. 
 
  
 
                                                                                                                          Bibliography 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52 
 
71
BIBLIOGRAPHY 
 
 
 
1. Ayse C., Nuriye A., 2004. Effect of Aloe vera Gel and Pulp Extract on the Liver 
Type-2 Diabetic Rat models. Biol. Pharm. Bull., Vol. 27, No. 5, 694 – 698. 
2. Rajendran A., Narayanan V., 2007. Separation and characterization of Phenolic 
Anthraquinones from Aloe vera. J. of Appl. Sci. Res. Vol. 3, No. 11, 1407 – 
1415.  
3. Zandi K., 2007. Antiviral activity evaluation of Aloe vera from South-West of 
Iran against Herpes Simplex Virus Type-2: An In-vitro Study. African J. 
Biotech., Vol. 6, No.15, 1770 – 1773. 
4. Etim OE., Faronbi EO., Usoh IF., Akpan EJ., 2006. The Protective Effect of Aloe 
vera Juice on Lindane Induced Hepatotoxicity and Genotoxicity. Pak. J. Pharm. 
Sci., Vol. 19, No. 4, 333 – 337. 
5.  Chitra P., Sajithlal G. B., Gowri C., 1998. Influence of Aloe vera on the Healing 
of Dermal wound in Diabetic Rats. J. Enthropharmacology Vol. 59, 195 – 201. 
6. Horacio A., Jose R., Flor H., German F., 1997. Cytotoxicity of low molecular 
weight fraction from Aloe vera (Aloe Barbedensis Miller) Gel. Toxicon Vol. 35, 
No. 9, 1423 – 1430. 
7. Dehdhari P., Ohadi A., Edra L., 2006. Aloe vera as semi-finish product like Gel, 
Powder and finish product like Aloe vera Drink or Fizzy Tablet. Ensymm 
Consorting of Biotechnology.   
8. Rana Singh P., Agarwal R., 2006. Mechanism of action of novel agent for 
prostate cancer chemo-preventive, Endocrine-related Cancer, Vol.13, 751 – 
778. 
9. Maenthaisong R., Chaiyakunapruk N., Niruntraporn S., 2007.The efficacy of aloe 
vera used for burn wound healing. Burn Vol. 23, 713 – 718. 
10. Christian Robe., Musch A., Peter Schirmacher S. Wolfgang K., Robert 
Hoffmann., 2005.  Acute Hepatitis induced by an Aloe vera preparation. World J. 
Gastroenterology, Vol.55, 69 – 75. 
 
                                                                                                                          Bibliography 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52 
 
72
11. Kathi Kemper J., Chiou V., 1999. Aloe vera. The Longwood Herbal Task Fource., 
http:/www. mcp.edu/ herbal/ default.htm. 
12.  Fletcher R., 1997. Listing of useful plant of the world, Australian New Crops, 
http:/www.silversplatter.com. 
13. Beatrinz V., Avila G., Senura D., Bruno Escalante, 1996. Anti-inflammatory 
activity of extracts from Aloe vera Gel. Journal of Enthropharmacology, Vol. 
55, 69 – 75. 
14. Admas M., 2007. The Aloe vera, A natural medicine for Cancer, cholesterol, 
diabetes, inflammation, IBS and other health conditions., http:/www. 
truthpublishing.com. 
15. Ramchandra C.T., Shrinivasa Rao P., 2008. Processing of Aloe vera Gel. 
American Journal of Agriculture and Biological Science, Vol.3, No.2, 502 – 
510. 
16. Teresa P., Gazzola M., Mucigant C., Parolin C., Dalla Vecchia F., 2000. Aloe-
emodin is a New Type of Anticancer agent with selective activity against 
Nuroectodermal tumor. Cancer Research.60, 2800 – 2804. 
17. Larry Tumlinson N., 1985. Method and Apparatus for Extraction of Aloe vera 
Gel. United State Patent, Patent No. 4,555,987. 
18. Coopusamy R.M., 2007. Traditional use, Antibacterial activity and Antifungal 
activity of Crude Extract of Aloe excelsa. American J. Biotechnology., Vol. 6, 
No.20, 2406 – 2410.  
19. Taiwo V.O., Olukunle O.A., Ozor I.C., Oyejobi A.T., 2005. Consumption of 
aqueous extract of raw Aloe vera leaves: Histopathological and Biochemical 
Studies in Rat and Tilapia. African Biomed. Sci., Vol. 8, 169 – 178. 
20.  Lachenmeier K., Kuepper U., Musshoff F., Burkhard M., Helmunt R., Drik W. 
Lachenmeier W. D., Quality Control of Aloe vera Beverages. EJEAF Che. Vol. 
4, No. 4, 1033 – 1042. 
 
21.Okamiura N., Norika Hine., Yukko Tateyama., Motoko Naakazawa., Toshihiro 
 Fujioka., Kunihide Mihashi., Akira Yagi.,1997. Three Chromones of Aloe Vera 
 leaves. www.elvister.com., Phytochemistry, Vol. 45, No. 7, 1511 – 1513.  
                                                                                                                          Bibliography 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52 
 
73
 
21. Yaawei Ni., Kenneth M., Ryszard Z., 2006. Pharmacological Composing Pectins 
having High Moleqular weight and Low Degree of methoxilation. United State 
Patent, No. 7,022,683. 
22. Reynolds T., Dweck A.C., 1996. Aloe vera leaf Gel: A review update. Journal of 
Enthropharmacology, 68, 3 – 37.  
23. Vogler BK, Ernst E., 1999. Aloe vera: a systematic review of its clinical 
effectiveness. Br J Gen Pract, 49, 823-8. 
24.  Saada HN, Ussama ZS, Mahdy AM. 2003 Effectiveness of Aloe vera on the 
antioxidant status of different tissues in irradiated rats. Pharmazie.58, 929-31. 
25. Vijayaraghavan R, Kumar P, Dubey DK, Singh R. 2001.  Evaluation of CC2 as a 
decontaminant in various hydrophilic and lipophilic formulations against sulphur 
mustard. Biomed Environ Sci., 15, 25-35.  
26.  Atkins KB, Lodhi IJ, Hurley IL, Hinshaw DB. 2000 N-acetylcysteine and 
endothelial cell injury by sulfur mustard. J Appl Toxicol, 20 Suppl 1, 125-8.  
28. Kandel A., Gbran W, 1979. Protection of gastric mucosa by Aloe vera. Journal 
of Drug Research 11, 191-196. 
29. Kameyama S., Shinho M, 1980, Wound healing compositions from Aloe 
arborescens extracts. Japanese patent 79,151,113.  
30. El Zawahry M, Hegazy MR, Helal M., 1973. Use of Aloe in treating leg ulcers   
and dermatoses. International Journal of Dermatology 12, 68-73. 
31. Gjerstad G., Riner TD, 1965 Current status of Aloe as a cure all. American 
Journal of Pharmacy 140, 58-64. 
32. Rovatti B, Brennan RJ. 1959. Experimental thermal burns - a comparative study           
 of the immediate and delayed histopathological changes in the skin in untreated 
 and treated thermal burns. Industrial Medicine and Surgery, Vol.28, No.8, 364-
 368. 
33. Ajabnoor, M.A., 1990. Effect of aloes on blood glucose levels in normal and       
 alloxan diabetic mice. Journal of Ethnopharmacology 28, 215–220. 
 
                                                                                                                          Bibliography 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52 
 
74
34. Davis, R.H., Kabbani, J.M., Maro, N.P., 1987. Aloe vera and wound healing. 
 Journal of the American Podiatric Medical Association 77, 165–169. 
35. Trease GE., Evans WC., Pharmacology, 15th edition, Page No. 51, 241- 242.  
36. Indian Medicinal Plant, Orient Longman Pvt. Ltd. 1994. Page No. 103. 
37. Atal CK., Kapur BM., Cultivation and Utilization of Medicinal Plants.     
 Regional Research Laboratory (Jammu- Tawi). 1982. Page No. 368- 374.  
38. Indian Pharmacopoeia. 1996., The Controller of Publications. Delhi, Page 
 No. A- 147.  
      39. Freshney RI., 1994. Culture of Animal Cell: A Manual of Basic Technique, 
 3rd Ed. Wiley- Liss, New York. 
40. Anshoo G., Singh S., Kulkarni A. S., Pant S.C. Vijayaraghayan R. 2005.     
 Protective effect of Aloe vera L. gel against sulphar mustured induced systemic 
 toxicity and skin lesions. Indian Journal of Pharmacology. Vol. 37, No.2, 103-       
 110.   
41. Lam Yuk Y., 2005. Characterization of infection bursal diseases virus induced 
 Apoptosis in chicken embryonic fibroblast, Summer Sci. Research Programs.4- 
 30.  
42. Cell Proliferation and Viability measurement 2003. Biochemica No.3, Cell 
 Biology 26-28.   
43. Agarayo O., Olale Ye M.T., Bello-Michal C.O. 2005. Comparative antimicrobial 
 activity of Aloe vera gel and leaf. African Journal of Biotechnology, Vol.4, 
 No.12, 1413-1414.  
44. Valerie AF., Bradbury F., Cameron P., Shakir E., Subita RR., William H. Stison.,  
 2003. In Vitro susceptibility of Shegella Flexineri and Streptococus Pyogenes to 
 inner gel of Aloe barbedensis Miller. Antimicrobial agent and Chemotherapy, 
 American Society for Microbiology, Vol. 47, No.3. 
45. Sehweizer M., 2006. Aloe the Health and Healing Plant. 4th Edition, Page 
 No. 55-58   
46. A. Ithart., B. Ooraikul., 2007. Research on thai medicinal plants for cancer 
 treatment. Advance in Medicinal Plant research, 287-317. 
 
                                                                                                                          Bibliography 
 
Department of Pharmaceutical Biotechnology, NCP, Erode-52 
 
75
47. Davic D., 2003. Glowing and Skin Wellness. Workhouse Publication, Page 
No. 20- 30. 
48. http:/www.wikipedia.com 
49. Kokate CK., Purohit P, Gokhle B., Text book of  Pharmacognosy, 18th edition, 
Nirali Prakashan,605, 181- 182. 
50. Fulda S., 2008. Betulinic Acid for Cancer Treatment and Prevention. Int. J. 
Mol. Sci. Vol. 9, Page No. 1096-1107.  
51. Fulda S., 2008. Betulinic Acid for Cancer Treatment and Prevention. Int. J. 
Mol. Sci. Vol. 9, Page No. 1096-1107.  
52. Balkmill F., 2000. A text book of Cytokine cell Biology. Oxford University 
Press. Page No. 23, 79. 
53. Bernard Glick R, Jack Pasternak J., Text book of Molecular Biotechnology, 
Principle and application of recombinant DNA. 3rd Edition, Page No. 615, 260. 
54. Richard A, Thomas J, Barbara A., Kuby J Text book of Immunology, 5th 
Edition, W.H. Freeman and Company, New York. Page No. 5, 9,38, 431. 
55. William Jakoby B., Ira Pastan H., Text book of Method in Enzymology, Vol. 
LV III, Cell Culture, Page No.5-81, 132-134. 
56. Kirk Kitchin T., 1999. Text book of Carcinogenicity, testing, predicting and 
interpreting chemical effect. Marcel Dekker Ine. Page No. 36-56. 
57. Robbins C, 7th Edition, Text book of Pathologic Basis of Diseases. Page No. 3, 
1230-1244. 
58.  Tripathi KD, 5th Edition, Text book of Essential of Medical Pharmacology. 
Page No. 627, 769-770. 
59. Rang HP, Dale, M.M Ritter, JM, 5th Edition. Text book of Pharmacology, 
Page No. 69-74, 696, 707. 
 
  
   
 
 
 
